MWNA
AUXL

Marshall Wace North America’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Marshall Wace North America’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-200,190
Closed -$3.33M – 775
2013
Q2 		$3.33M Buy
+200,190
New +$3.2M 0.26% 129

Other funds holding AUXL

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Marshall Wace North America's AUXL Position: Q3 2013 in Review

Marshall Wace North America sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q3 2013, closing a stake of 200,190 shares — an estimated $3.33M sold.

Marshall Wace North America first reported a position in AUXL in Q2 2013 and held it in 1 quarter. The position peaked at $3.33M in Q2 2013. 150 funds tracked by Wall St. Rank hold AUXL as of Q3 2013.

  • Marshall Wace North America reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q3 2013 after selling out during the quarter.
  • Marshall Wace North America sold 200,190 AUXILIUM PHARAMCEUTICALS INC shares in Q3 2013, an estimated $3.33M.
  • Marshall Wace North America first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 1 quarter.
  • Marshall Wace North America's AUXILIUM PHARAMCEUTICALS INC position peaked at $3.33M in Q2 2013.
  • 150 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q3 2013.

Based on Marshall Wace North America's 13F filing for Q3 2013, filed 12 Nov 2013.